Chimerism in health and potential implications on behavior: A systematic review.
Brandon N JohnsonErik A EhliGareth E DaviesDorret I BoomsmaPublished in: American journal of medical genetics. Part A (2020)
In this review, we focus on the phenomenon of chimerism and especially microchimerism as one of the currently underexplored explanations for differences in health and behavior. Chimerism is an amalgamation of cells from two or more unique zygotes within a single organism, with microchimerism defined by a minor cell population of <1%. This article first presents an overview of the primary techniques employed to detect and quantify the presence of microchimerism and then reviews empirical studies of chimerism in mammals including primates and humans. In women, male microchimerism, a condition suggested to be the result of fetomaternal exchange in utero, is relatively easily detected by polymerase chain reaction molecular techniques targeting Y-chromosomal markers. Consequently, studies of chimerism in human diseases have largely focused on diseases with a predilection for females including autoimmune diseases, and female cancers. We detail studies of chimerism in human diseases and also discuss some potential implications in behavior. Understanding the prevalence of chimerism and the associated health outcomes will provide invaluable knowledge of human biology and guide novel approaches for treating diseases.
Keyphrases
- allogeneic hematopoietic stem cell transplantation
- endothelial cells
- healthcare
- public health
- acute lymphoblastic leukemia
- acute myeloid leukemia
- pluripotent stem cells
- case control
- single cell
- randomized controlled trial
- health information
- pregnant women
- gene expression
- drug delivery
- adipose tissue
- cell therapy
- copy number
- young adults
- bone marrow